⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Fortune et Korn Ferry dévoilent le palmarès 2026 « World's Most Admired Companies™ » de Fortune USA - Français USA - English USA - English
prnewswire.com
KFY
AAPL
MSFT
AMZN
NVDA
AMD
WDAY
JPM
TGT
PEP
NVO
ADBE
WHR
MET
PG
GE
LMT
ACN
COF
MU
Semaglutide Market Size to Reach USD 59.75 Billion by 2033, Experiencing High Demand for an Efficient Treatment for Diabetes and Obesity – SNS Insider
globenewswire.com
NVO
HIMS
CAL
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
NVO
IONS
PFE
REGN
LXRX
VRTX
LLY
Novo Nordisk introduces "There's Only One Ozempic®" campaign, reuniting Justin Long and John Hodgman
prnewswire.com
NVO
Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes
globenewswire.com
NVO
Lipovive Investigated (2026) Is Lipovive the Natural Ozempic? A Research-Based Look at Its Weight Loss Potential
globenewswire.com
NVO
Donovan Mackie turns pro with Team Novo Nordisk for 2026
prnewswire.com
NVO
Refills GLP-1 Weight Loss Guide 2026: Branded vs Compounded Options, Eligibility, Pricing Factors, and FDA Safety Notes
accessnewswire.com
NVO
LLY
SkinnyRx GLP-1 Weight Loss Guide 2026: Injectable vs Sublingual vs Tablet Options (Semaglutide + Tirzepatide)
accessnewswire.com
NVO
LLY
Germany's BMZ, Novo Nordisk Foundation, Rockefeller Foundation, and WFP Launch School Meals Accelerator to Feed 100 Million Children by 2030
prnewswire.com
NVO